Skip to main content
. 2022 Sep 16;26(4):295–318. doi: 10.4103/2230-8210.356236

Table 7.

Comorbidity assessment in a patient with obesity

Metabolic comorbidities Type 2 diabetes mellitus, hypertension, dyslipidemia, hyperuricemia, non-alcoholic fatty liver disease, cholelithiasis and polycystic ovary syndrome
Mechanical impact Osteoarthritis, obstructive sleep apnea, venous stasis, acid reflux, bladder incontinence and plantar fasciitis
Psychological impact Depression, eating disorders, addictions, psychosis, attention deficit, insomnia, posttraumatic stress disorder.